Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Head and Neck Cancer Study
TCTR20160606004Phase 2Not yet recruiting
- Sponsor
- Immunovative Therapies
- Start
- Sep 2016
- Countries
- 1
01
Overview
Phase 2 trial in head and neck cancer (HNC), sponsored by Immunovative Therapies. Planned start Sep 2016; status: not yet recruiting.
02
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on TCTR20160606004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160606004.